OpenVSafe by OpenVAERS
Search V-safe

UNE-37321-23244

3 vaccinations 3 coded responses 28 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
208 / MD
Registered
2021-05-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-18
    Registered in v-safe
  3. 2021-05-18
    Dose 2 — Pfizer-BioNTech
  4. 2021-05-18
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Abdominal pain
    Adult check-in
  5. 2021-05-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  6. 2021-05-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-05-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-05-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-05-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-06-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-08-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-11-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-01-25
    Dose 3 — Pfizer-BioNTech
  20. 2022-01-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Brain fog — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Brain fog
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-01-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2022-01-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · None
    Adult check-in
  23. 2022-01-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2022-02-01
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2022-02-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-02-15
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-02-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-03-01
    Survey response — day 35, dose 3
    MedDRA: Dyspnoea, Headache, Sleep apnoea syndrome — Feeling: Good
    Free text: Sleep apnea Headaches Shortness of breath
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-03-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-04-26
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-07-26
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  32. 2023-01-25
    Survey response — 12 months, dose 3
    MedDRA: Pregnancy test positive, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  33. 2023-01-25
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  34. 2023-01-26

Vaccinations

DoseDateManufacturerCo-administered
12021-04-27Pfizer-BioNTech
22021-05-18Pfizer-BioNTech
32022-01-25Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — days 1–6 daily, dose 3

2022-01-27

Systemic reaction (other): Brain fog

Release 11 — day 35, dose 3

2022-03-01

Symptoms: Sleep apnea Headaches Shortness of breath

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDyspnoea · · ✓
SDHeadache · · ✓
SDPregnancy test positive · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSleep apnoea syndrome · · ✓
SROBrain fog · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…